Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments.

MLA

Wu, Vin-Cent, et al. “Long-Term Mortality and Cardiovascular Events in Patients with Unilateral Primary Aldosteronism after Targeted Treatments.” European Journal of Endocrinology, vol. 186, no. 2, Dec. 2021, pp. 195–205. EBSCOhost, https://doi.org/10.1530/EJE-21-0836.

APA

Wu, V.-C., Wang, S.-M., Huang, K.-H., Tsai, Y. C., Chan, C.-K., Yang, S.-Y., Lin, L.-Y., Chang, C.-C., Lu, C.-C., Lin, Y.-H., Chen, Y.-M., & Chueh, J. S. (2021). Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments. European Journal of Endocrinology, 186(2), 195–205. https://doi.org/10.1530/EJE-21-0836

Chicago

Wu, Vin-Cent, Shuo-Meng Wang, Kuo-How Huang, Yao Chou Tsai, Chieh-Kai Chan, Shao-Yu Yang, Lian-Yu Lin, et al. 2021. “Long-Term Mortality and Cardiovascular Events in Patients with Unilateral Primary Aldosteronism after Targeted Treatments.” European Journal of Endocrinology 186 (2): 195–205. doi:10.1530/EJE-21-0836.